Glicolic-H

Quick links to important sections

Glicolic-H

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glicolic-H

Property Description
Active Ingredients Hydroquinone and Glycolic Acid
Form Topical cream or lotion
Pharmacological Class Depigmenting agent and Keratolytic agent
Common Use Type Addressing non-uniform skin appearance
Origin Synthetic (Hydroquinone) and Derived (Glycolic Acid)

What Type of Medicine is Glicolic-H and What is its Classification?

Glicolic-H is classified as a specialized, fixed-dose combination dermatological preparation intended for cutaneous application. It is a topical medication that merges the actions of a primary depigmenting agent and a keratolytic agent. This formulation represents a clinically recognized strategy for addressing skin characteristics where multiple therapeutic mechanisms are beneficial, positioning it as a prescription-strength product often containing higher concentrations of active ingredients than over-the-counter options.

Glicolic-H Composition: Ingredients, Form, and Origin

The preparation contains two active ingredients: Hydroquinone and Glycolic Acid. Hydroquinone (INN: benzene-1,4-diol) is recognized as a potent skin lightening agent, with a primary mechanism of interfering with the synthesis of the skin pigment melanin. The second component, Glycolic Acid, is an alpha-hydroxy acid that functions as a keratolytic agent, facilitating the natural shedding of the skin's outer layer. The medicine is supplied as a topical cream or lotion, serving as a stable semisolid vehicle for the controlled, simultaneous delivery of both components.

General Purpose of Glicolic-H Combination Therapy

The overall purpose of this specific combination therapy is to support the visual uniformity of the skin by managing both pigment creation and surface renewal. The dual action means the medicine works on two complementary fronts: the Hydroquinone component helps limit the formation of new pigment, and the Glycolic Acid component aids in the exfoliation of existing surface cells. This synergy is utilized in therapeutic regimens focused on improving the skin’s tone and overall appearance.

What side effects are possible with Glicolic-H?

Official Safety Profile and Adverse Reactions

The safety profile for this topical combination is formally structured by adverse reactions that primarily affect the Skin and Subcutaneous Tissue Disorders system, representing the most frequent events reported in regulatory documentation.

Localized reactions are common and often reported during the initial phase of treatment. These may include a burning sensation, stinging, erythema (redness), and skin dryness or irritation. These effects are typically associated with the medicine's topical application and the keratolytic action of the Glycolic Acid component.


Serious Adverse Reactions and Key Constraints

Official regulatory documents highlight the potential for serious adverse reactions, particularly those linked to the Hydroquinone component and long-term use. Exogenous Ochronosis is a documented serious concern, described as a gradual, blue-black discoloration of the skin associated with prolonged or long-term use.

Safety notes also address the risk of hypersensitivity reactions. The medicine is contraindicated in individuals with a known history of sensitivity or allergic reaction to its active ingredients. Severe reactions such as blistering, severe allergic contact dermatitis, or sulfite-related reactions (if the formulation contains sulfites) are documented as requiring immediate attention.


Population-Specific Safety Notes

The regulatory profile includes specific limitations for certain groups. Safety and effectiveness are not established for pediatric patients below the age of 12 years. Official documentation classifies the medicine's pregnancy risk as Category C, meaning it should only be used if clearly necessary, as the potential for fetal harm is unknown. It is also unknown whether the drug is excreted in human milk.

Overdose and Emergency Response

The official overdose profile for this topical combination is defined by the regulatory guidance on two primary exposure scenarios: excessive topical use and accidental ingestion.

Documented Manifestations and Risks

Excessive topical application of Glicolic-H is documented to result in an exaggerated local inflammatory response, severe irritation, and potentially chemical burns, primarily due to the Glycolic Acid component. Accidental ingestion presents the risk of systemic toxicity. This can include CNS effects, convulsions, and the potential development of methemoglobinemia, a severe condition affecting blood oxygen levels, as noted in regulatory documents. Furthermore, some formulations may contain sulfites, which carry a documented risk of triggering severe allergic-type reactions, including life-threatening asthmatic episodes. Long-term, excessive use is linked to Exogenous Ochronosis, a persistent blue-black skin darkening.


When Immediate Medical Help Is Required

Regulatory instructions mandate that patients seek immediate medical attention or call a Poison Control Center immediately following any accidental ingestion or if signs of a severe allergic reaction are observed. In overdose situations, management is generally symptomatic and supportive. For accidental contact with eyes or mucous membranes, regulatory documents state that the affected area should be washed thoroughly with large amounts of water. Hospital monitoring may be required following suspected systemic toxicity or ingestion.

Therapeutic Uses of Glicolic-H

What Glicolic-H Treats: Main Uses and Benefits

Glicolic-H is commonly used in addressing conditions characterized by persistent and noticeable discoloration. It is relevant across therapeutic areas where pigment correction and surface renewal are beneficial for achieving visual skin uniformity.

Correction of Established Dark Spots and Patches

This medication is applied in addressing acquired hyperpigmentation disorders, helping with the appearance and intensity of entrenched dark patches. This medication is relevant for managing conditions such as melasma, solar lentigines (age spots or sun spots), and lingering post-inflammatory hyperpigmentation (PIH) resulting from previous skin events. The use of this medication contributes to easing the cosmetic challenge of chronic discoloration, and may assist with the fading and lightening of affected areas.

“This medicine is relevant for easing the symptomatic burden of persistent discoloration in challenging therapeutic contexts.”

Management of Uneven Skin Tone and Texture

Glicolic-H is applied in addressing situations where patients experience a dual symptomatic burden of mottled skin coloration and associated surface texture irregularities. It is relevant for therapeutic plans aimed at improving the skin's overall clarity and smoothness. This focus on both color and texture may support improved visual uniformity, and assists with enhancing the overall appearance. It is commonly used in contexts where the discoloration is established or chronic, providing additional symptomatic support for moderate to persistent pigmentary challenges.


Quick Fact: Relief for Pigmentation
Glicolic-H supports the management of hyperpigmentation symptoms and uneven texture, which helps improve day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

The eligibility for using Glicolic-H is strictly defined by official regulatory documentation for its active components.

Populations Who Must Not Use Glicolic-H (Contraindications)

Use of this medication is contraindicated if an individual has a known history of hypersensitivity or allergic reaction to Hydroquinone or any other ingredient in the formulation, including sulfites if present. Furthermore, the product must not be used if a skin test results in a severe inflammatory response such as itching or vesicle formation. Application is also prohibited for areas of the skin that are cut, abraded, or sunburned.

Age and Conditional Use Restrictions

The medicine is permitted for use in adults and adolescents 12 years of age and older. Safety and effectiveness have not been established for children under 12 years of age.

For pregnant women, Glicolic-H is classified as Pregnancy Category C and should be used only if clearly needed, due to unestablished data regarding potential fetal harm. Caution is required when administering the medicine to a nursing mother, as it is not known whether the drug is excreted into human milk.

There are no explicit regulatory limitations documented for use in patients with hepatic or renal impairment. However, the medicine must be discontinued immediately if signs of exogenous ochronosis (blue-black skin discoloration) develop during treatment.

What should I know about interactions with other medicines?

Interactions with Other Topical and Systemic Products

The interaction profile for Glicolic-H is defined by two primary regulatory constraints: localized chemical incompatibilities and the potential for additive pharmacodynamic effects. This information is derived from official government labeling for the active ingredients.

Chemical Incompatibility and Staining

Strict co-application restrictions are documented for peroxide-containing products, including substances such as benzoyl peroxide and hydrogen peroxide. The official regulatory documentation states that the simultaneous application of these substances with Glicolic-H results in a temporary, localized, dark brown or black staining of the skin. This outcome is classified as a specific chemical interaction that modifies the substance at the site of cutaneous administration.

Additive Local Effects and Restrictions

Due to the product’s inherent keratolytic action, regulatory documentation prohibits the concurrent use of other topical irritants or keratolytic agents. This restriction is based on the potential for an additive pharmacodynamic effect, which may heighten the risk of excessive local skin reactions such as dryness, erythema, and peeling. Restricted topical substances include abrasive or medicated soaps, cleansers, and products containing high concentrations of alcohol, spices, astringents, or lime. Furthermore, caution is advised concerning the co-administration of photosensitizing medications (topical or systemic), as these agents may reinforce the active components' known increase in skin sensitivity to ultraviolet light.

Mechanism of Action

Enzymatic Inhibition of Melanin Synthesis

The mechanism of Hydroquinone involves the competitive inhibition of the enzyme tyrosinase, the key molecular catalyst required for the initial steps of melanin formation within melanocytes. This suppression of the biosynthetic pathway limits the rate of new pigment synthesis. This action establishes a physiological ceiling on the amount of pigment available for transfer into surrounding skin cells, resulting in a reduced epidermal pigment load over time.

Modulation of Epidermal Cell Turnover

Glycolic Acid functions as a keratolytic agent by chemically weakening the corneodesmosomes (intercellular bonds) holding dead cells together in the stratum corneum, thereby accelerating the natural desquamation pathway. This faster cell replacement contributes to the more rapid shedding of existing, pigmented cells and facilitates the cutaneous penetration of the pigment inhibitor. This synergy ensures the active engagement of two distinct physiological mechanisms: control of pigment formation and acceleration of pigment clearance.

Dosage and Administration Information

Official Administration Guidelines for Glycolic Acid Formulations

Products containing Glycolic Acid (an Alpha Hydroxy Acid or AHA) are subject to specific usage protocols. These protocols primarily address sun sensitivity and product formulation requirements for consumer use.

Administration Scope Standard Usage Protocols
Route of Administration Topical application to the skin or mucous membrane.
Dosing/Concentration For general consumer products: maximum 10% Glycolic Acid, with a final product pH of 3.5. Higher concentrations (up to 70%) are restricted to compounding by specialized facilities.
Frequency Pattern Daily use (for leave-on products) or short-term, discontinuous use followed by rinsing.
Age-Group Rules No specific age-group dosage adjustments are documented. Products containing AHAs are generally not recommended for use on children and infants.

Mandatory Procedural Steps (Sun Protection)

Because topical application of AHAs may increase the skin's sensitivity to the sun and the possibility of sunburn, standard labeling guidelines involve adherence to the following special procedural conditions:

  • Use Sunscreen: Apply a sunscreen daily.
  • Wear Protective Clothing: Wear protective clothing over treated areas.
  • Limit Sun Exposure: Limit sun exposure while using the product and for a full week after stopping the product.

These instructions define the parameters for product formulation and administration, focusing on limiting user exposure to UV radiation both during and immediately following the course of use. Adherence to these steps is required for the safe use of AHA-containing products.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Glicolic-H

The research base for Glicolic-H, which contains Hydroquinone and Glycolic Acid, has been the subject of numerous clinical evaluations. The available data primarily describe the patterns observed in controlled study settings rather than predicting individual outcomes.


Evidence for Use in Melasma and Acquired Hyperpigmentation

Research has primarily focused on how this combination was studied for individuals with acquired dark patches and persistent discoloration, notably melasma. Studies for this indication include Randomized Controlled Trials (RCTs), often employing specific designs such as split-face comparative trials. Systematic reviews, which synthesize data from multiple independent studies, also contribute to the evidence landscape for topical agents in this area.

The studies monitored changes in pigmentation using validated, objective tools. Researchers primarily used the Melasma Area and Severity Index (MASI), which is a clinical endpoint for measuring the extent and intensity of the discoloration. Investigators reported measurements of the observed evolution of pigmentation severity and extent over the defined time intervals.

The available evidence is primarily derived from short-term data. The follow-up durations for many key trials typically centered on 12 weeks (3 months). While research has explored the application in adults with moderate to severe melasma, long-term effects are not fully established.

Study Outcomes and Measures

Outcomes were related to the visual appearance of discoloration and were quantified using established clinical scales and technical instruments. Studies focused on episodes where symptoms become more noticeable, measuring symptom change using standardized protocols. Research provides context but not individual predictions, as study results reflect the specific conditions under which they were conducted.


Long-Term Studies and Follow-Up Data

The majority of pivotal studies for the Glicolic-H combination are designed for short-term symptom changes and typically have primary endpoints at 3 months. While some trials included extended observational settings for up to seven months, the long-term effects are not fully established beyond the intermediate duration of these studies.

Studies report how symptoms evolved in the observed populations, noting that recurrence of the hyperpigmentation may occur after treatment ceases, an outcome often described in the literature. Therefore, there is limited information for long-term outcomes regarding the durability of any observed changes over multiple years of use or observation.


What is Still Uncertain About Glicolic-H Research

Follow-up durations were limited in many key trials, meaning the full picture of the condition's stability or the patterns observed over many years is not fully established. Researchers have identified that the recurrence of hyperpigmentation after treatment requires further long-term investigation. Evidence remains limited regarding the stability of changes achieved after 6 months of use, indicating that research is ongoing in this area.

Key Studies & References

  1. Melasma: Diagnosis and treatment (American Academy of Dermatology - AAD)
  2. Label: HYDROQUINONE 4%- hydroquinone cream (DailyMed/FDA Monograph Information)

Frequently Asked Questions (FAQ)

Common questions about Glicolic-H (FAQ)


Q: Is Glicolic-H a steroid cream?

A: Glicolic-H is classified in regulatory documents as a combination topical preparation. Its active components are defined as a depigmenting agent (hydroquinone) and a keratolytic agent (glycolic acid). Official documents do not classify the product as a corticosteroid (steroid) cream.


Q: What is Glicolic-H used for besides the main conditions listed?

A: The regulatory label indicates the product's use for treating a variety of hyperpigmented skin conditions beyond melasma. These may include chloasma, freckles, senile lentigines (liver spots), and other areas of unwanted melanin hyperpigmentation. The product is intended to support the visual uniformity of the skin in these specific areas.


Q: How quickly does Glicolic-H start to show effects?

A: Clinical investigations have noted that visible results may begin to appear after approximately four to six weeks of consistent use, with more significant observations after eight to twelve weeks. Regulatory guidance advises discontinuing the product if no lightening effect is noted after two months.


Q: Can Glicolic-H be used on sensitive areas of the body?

A: Official information states the product is for external topical use only. Official information advises against applying the product to the eyes, lips, and inside the nose or mouth. Additionally, the medicine should not be applied to skin that is cut, abraded, sunburned, chapped, windburned, or irritated.


Q: Does Glicolic-H cause skin thinning over time?

A: Official documents for similar prescription combination products have documented 'thinning of the skin with easy bruising' as a possible serious adverse reaction. This is typically associated with prolonged use. The active ingredient glycolic acid is known for its exfoliating (keratolytic) effect on the outermost layer of the skin.


Q: Is Glicolic-H available over the counter?

A: The primary active component of Glicolic-H, hydroquinone at 4% concentration, is regulated as a human prescription drug. Concentrations this high are generally only available by prescription.


Q: Does Glicolic-H have a generic version available?

A: The regulatory product (Hydroquinone 4% cream) is a prescription drug. It is produced by various manufacturers and is available in generic form.


Q: Can Glicolic-H be applied under makeup or moisturizer?

A: Clinical protocols and regulatory guidance for this type of medication indicate that moisturizers and cosmetics may be used during the day in conjunction with treatment. These complementary products are usually applied during the day.


Q: What if I accidentally use Glicolic-H more often than recommended on the label?

A: Using the product more often than directed may cause unwanted local side effects, such as excessive skin irritation or redness. Although no systemic reactions have been reported from topical overuse, in case of accidental ingestion, official guidance advises contacting a poison control center.


Q: Can men use Glicolic-H as well as women?

A: The regulatory indication for the primary active ingredient is for hyperpigmented skin conditions, such as chloasma and melasma, which can affect any person. Official documentation does not restrict the use of the medicine based on the patient's sex.


Q: If I miss a dose of Glicolic-H, should I double the next application?

A: Regulatory directions provide guidance on managing missed applications, which often involves applying the dose as soon as it is remembered. However, if it is almost time for the next scheduled application, the missed dose should be skipped. Regulatory directions caution against applying extra product to make up for a missed application.


Q: Has Glicolic-H been recalled or had any major safety warnings recently?

A: Regulatory bodies periodically issue public health warnings for products containing hydroquinone that are marketed illegally as cosmetics. Regulatory guidance suggests that individuals should rely only on officially approved prescription products. All users should be aware of documented long-term risks like Exogenous Ochronosis.


Q: Can Glicolic-H be used simultaneously with laser treatment or microdermabrasion?

A: Official regulatory documents do not contain specific timing instructions. However, professional guidance indicates that use of the active ingredient, hydroquinone, is typically interrupted before certain procedures to prevent heightened sensitivity. It is reintroduced only after the skin has fully healed, which may take several weeks.


Q: What evidence exists regarding Glicolic-H's use in combination with moisturizing agents?

A: Clinical trials of this combination have observed that local irritation may resolve with the temporary cessation of the cream and the addition of moisturizers. Regulatory guidance for related prescription combinations also permits the use of moisturizers during the day.


Q: What are the components of Glicolic-H that are considered inactive ingredients?

A: Inactive ingredients are components that aid in product delivery but do not have a therapeutic effect. Ingredients listed in regulatory labels for similar formulations include components such as: Alcohol, Glycerin, Kojic Acid, Xanthan Gum, Purified Water, and various other oils and emollients.


Q: Do official prescribing documents mention any specific psychological side effects?

A: The official safety profile for topical hydroquinone primarily focuses on local skin effects (skin and subcutaneous tissue disorders). Risk assessments for the active component have identified the Central Nervous System (CNS) as a sensitive endpoint, but the primary focus of the topical safety profile is on local skin effects.


Q: Is Glicolic-H the same as a regular glycolic acid product?

A: The regulatory product is classified as a prescription skin bleaching cream containing both the depigmenting agent hydroquinone and the keratolytic agent glycolic acid. This makes it distinct from single-ingredient glycolic acid products, which are often available over-the-counter and typically contain lower concentrations.


Q: What happens if I stop using Glicolic-H suddenly?

A: Clinical studies have indicated that a recurrence of the hyperpigmentation may occur after treatment ceases. Official information also indicates that if sun exposure is not continuously avoided, the bleached areas may repigment.


Q: How long can a person safely use Glicolic-H continuously?

A: Most clinical trials have focused on short-term use, and regulatory guidance advises discontinuing treatment if no lightening effect is noted after two months. Prolonged use is associated with the risk of Exogenous Ochronosis (blue-black darkening of the skin), a documented serious adverse reaction.


Q: What should I do if my skin becomes very red after using Glicolic-H?

A: Severe skin redness, burning, or stinging is a sign that regulatory warnings suggest should be discussed with a healthcare professional. While minor redness is a common local reaction, severe irritation warrants attention.


Q: Does Glicolic-H contain any known allergens?

A: The product is strictly contraindicated in patients with a known history of allergy or sensitivity to hydroquinone or any of its ingredients. Regulatory labels warn that some formulations may contain sodium metabisulfite, a sulfite that can cause allergic-type reactions, particularly in susceptible people, such as those with asthma.


Q: What is the typical duration of a course of Glicolic-H treatment?

A: Clinical guidance has often suggested use for three to six months, with a subsequent rest period. However, regulatory guidance advises discontinuing use if no lightening effect is noted after two months of treatment.


Q: Is Glicolic-H a common cause of allergic reactions?

A: Regulatory information notes that the overall prevalence of sensitivity to sulfites, a potential allergen in the product, is unknown in the general population but is observed more frequently in asthmatic individuals. The product is strictly contraindicated for anyone with a known history of sensitivity or allergic reaction to its components.


Q: What are the signs of a serious side effect from Glicolic-H that require medical attention?

A: Regulatory warnings indicate that serious signs have been documented, including: blue or black darkening of the skin (Exogenous Ochronosis), blistering, oozing, severe skin redness, severe burning, severe dryness, or cracking.


Q: Is Glicolic-H known to cause pigmentation issues in darker skin tones?

A: Official warnings state that hydroquinone may produce Exogenous Ochronosis, a gradual blue-black darkening of the skin. Regulatory documents note that the majority of patients developing this condition are Black, Hispanic, or Caucasian individuals with darker skin tones.


Q: What is the general patient expectation for achieving results with Glicolic-H?

A: Regulatory guidance advises discontinuing treatment if no lightening effect is observed after two months of use. The regulatory focus is on improvement in hyperpigmentation, though official information notes that repigmentation may occur if sun exposure is not continuously avoided during and after the course of treatment.

How should Glicolic-H be stored and disposed of?

Official Storage and Disposal Profile

The storage and disposal requirements for Glicolic-H are strictly based on regulatory mandates to preserve the product's chemical stability and potency.

Storage Requirement Official Guidance
Temperature Store in the refrigerator (do not freeze).
Protection Keep the container securely closed and protected from light.
Handling Keep the medicine in its original container.
Child Safety Keep all medicine out of the reach of children.

Disposal instructions require patients to not keep outdated medicine or medicine no longer needed. Consult a pharmacist or healthcare professional for specific instructions on how to properly dispose of the medicine and its container, ensuring compliance with local, regional, and national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Glicolic-H found in:

A-Z Index: